Income Statement

PHIBRO ANIMAL HEALTH CORP

PAHC
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Jun 30, 2025 2025 FY Jun 30, 2024 2024 FY Jun 30, 2023 2023 FY Jun 30, 2022 2022 FY Jun 30, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY
Revenue
1,296.22 1,017.68 977.89 942.26 833.35 800.35 - 819.98 764.28 751.53 748.59 691.91
Cost of Revenue
896.27 704.59 679.65 656.86 561.97 543.47 563.37 553.10 - - - -
Gross Profit
399.94 313.09 298.24 285.40 271.38 256.88 264.62 266.88 248.24 239.03 236.37 207.78
Operating Expenses
289.48 259.78 226.39 206.41 196.51 187.69 181.40 167.95 150.31 153.29 148.70 143.98
Research & Development
- - - - - - - - - - - -
Selling, General & Administrative
289.48 259.78 226.39 206.41 196.51 187.69 181.40 167.95 150.31 153.29 148.70 143.98
Other Operating Expenses
- - - - - - - - - - - -
Operating Income
110.47 53.32 71.85 78.99 74.87 69.19 83.23 98.93 97.93 85.74 87.67 63.79
Non-Operating Income
42.47 42.40 17.78 6.66 8.40 13.68 11.72 10.86 17.39 8.98 8.91 57.49
Interest Income
- - - - - - - - - - - 0.12
Interest Expense
- - 18.68 12.69 13.72 14.61 13.68 13.60 16.87 16.85 14.55 29.89
Other Non-Op Income / Expense
- - - - - - - - - - - -
Income Before Tax
67.99 10.92 54.07 72.33 66.47 55.51 71.51 88.07 80.54 76.76 78.76 6.31
Income Tax Expense
19.73 8.50 21.47 23.15 12.08 21.96 16.79 23.19 15.93 -5.97 18.48 9.44
Non-Controlling Interest
- - - - - - - - - - - -
Net Income
48.26 2.42 32.61 49.18 54.39 33.55 54.71 64.88 64.62 82.73 60.28 -3.13
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Jun 30, 2025 2025 FY Jun 30, 2024 2024 FY Jun 30, 2023 2023 FY Jun 30, 2022 2022 FY Jun 30, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY
Depreciation & Amortization
- - - - - - - - - - - -
EBITDA
156.07 89.49 105.86 111.69 106.75 101.54 110.79 125.87 123.94 109.20 109.27 85.25
Earnings Per Share (Basic)
1.19 0.06 0.81 1.21 1.34 0.83 1.35 1.61 1.63 2.11 1.55 -
Diluted EPS
1.19 0.06 0.81 1.21 1.34 0.83 1.35 1.61 1.61 2.07 1.51 -
Weighted Average Shares
40.52 40.50 40.50 40.50 0.04 0.04 0.04 0.04 39.52 39.25 0.04 -
Diluted Weighted Avg Shares
40.68 40.52 40.50 40.50 0.04 0.04 0.04 0.04 40.04 39.96 0.04 -
Comprehensive Income
48.26 2.42 39.51 49.18 69.48 33.55 54.71 64.88 70.96 82.73 60.28 -2.29